Whittier Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Whittier Trust CO

$6.97 Billion
Q2 2024

A detailed history of Whittier Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Whittier Trust CO holds 765 shares of REGN stock, worth $797,237. This represents 0.01% of its overall portfolio holdings.

Number of Shares

765

Previous 774 1.16%

Holding current value

$797,237

Previous $744,000 8.06%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$883.2 - $1071.19 $7,948 - $9,640	-9 Reduced 1.16%	765 $804,000
Q4 2023 Jan 11, 2024	BUY	$775.18 - $881.7 $376,737 - $428,506	486 Added 168.75%	774 $679,000
Q3 2023 Oct 27, 2023	BUY	$692.45 - $844.37 $24,235 - $29,552	35 Added 13.83%	288 $237,000
Q2 2023 Jul 24, 2023	SELL	$700.03 - $830.35 $1,400 - $1,660	-2 Reduced 0.78%	253 $181,000
Q1 2023 Apr 21, 2023	BUY	$680.49 - $826.97 $59,883 - $72,773	88 Added 52.69%	255 $209,000
Q3 2022 Oct 21, 2022	SELL	$573.97 - $724.32 $14,923 - $18,832	-26 Reduced 13.47%	167 $115,000
Q2 2022 Jul 28, 2022	BUY	$548.35 - $738.84 $14,257 - $19,209	26 Added 15.57%	193 $114,000
Q1 2022 Apr 29, 2022	SELL	$595.12 - $698.43 $7,141 - $8,381	-12 Reduced 6.7%	167 $117,000
Q4 2021 Jan 19, 2022	BUY	$543.48 - $670.97 $76,630 - $94,606	141 Added 371.05%	179 $113,000
Q2 2021 Jul 29, 2021	SELL	$472.8 - $558.54 $8,037 - $9,495	-17 Reduced 30.91%	38 $21,000
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $6,696 - $8,511	-14 Reduced 20.29%	55 $27,000
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $8,171 - $9,873	-15 Reduced 17.86%	69 $39,000
Q2 2020 Jul 10, 2020	BUY	$493.32 - $643.92 $13,812 - $18,029	28 Added 50.0%	84 $53,000
Q1 2020 Apr 27, 2020	SELL	$336.18 - $494.43 $8,068 - $11,866	-24 Reduced 30.0%	56 $27,000
Q4 2019 Jan 31, 2020	SELL	$274.13 - $376.51 $37,555 - $51,581	-137 Reduced 63.13%	80 $30,000
Q3 2019 Oct 18, 2019	BUY	$273.46 - $318.39 $53,051 - $61,767	194 Added 843.48%	217 $60,000
Q1 2019 Apr 29, 2019	SELL	$372.08 - $439.57 $16,743 - $19,780	-45 Reduced 66.18%	23 $9,000
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $15,111 - $18,136	45 Added 195.65%	68 $25,000
Q2 2018 Jul 27, 2018	SELL	$284.6 - $344.99 $853 - $1,034	-3 Reduced 11.54%	23 $8,000
Q2 2018 Jul 20, 2018	SELL	$284.6 - $344.99 $9,107 - $11,039	-32 Reduced 55.17%	26 $7,000
Q4 2017 Feb 07, 2018	SELL	$358.63 - $469.95 $8,607 - $11,278	-24 Reduced 29.27%	58 $22,000
Q3 2017 Oct 23, 2017	BUY	$431.38 - $504.0 $35,373 - $41,328	82	82 $37,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Account

Whittier Trust CO Regeneron Pharmaceuticals, Inc. Transaction History